SkyePharma names new CFO
This article was originally published in Scrip
Executive Summary
SkyePharma has named Andrew Derodra chief financial officer and executive director – effective from the fourth quarter 2013. Mr Derodra joins from UK-based, multinational agribusiness Tate & Lyle, where he has been group vice-president of finance and control since 2011. He succeeds Peter Grant, who was appointed chief executive officer of SkyePharma in January 2012 but retained responsibility for the company's financial affairs.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.